WaveMan · Form 4
Nodelman Oleg insider trades
> Search tickers & screens ⌘K
LIVE

Nodelman Oleg insider trades

Nodelman Oleg has filed 7 Form 4s with the SEC that we hold, for Zymeworks Inc. (ZYME) (Director, 10% owner), Nuvation Bio Inc. (NUVB) (Director), Aktis Oncology, Inc. (AKTS) (Director) and PANA (Director, 10% owner). Across all of them we count 10 purchases worth $63.5M and 0 sales worth $0 reported on Form 4. In the last 12 months: 2 purchases ($40.0M) and 0 sales ($0). The largest single trade was a purchase of 2,077,779 shares of Aktis Oncology, Inc. worth $37.4M, dated 2026-01-12. The first filing on our record is dated 2021-11-02 and the latest 2026-01-12.

Zymeworks Inc. (ZYME)

Director, 10% owner · 3 filings · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-03-11P, purchase reported on Form 4320,690$3.7M2025-03-13
2025-03-12P, purchase reported on Form 4292,934$3.6M2025-03-13
2025-03-13P, purchase reported on Form 4468,356$5.8M2025-03-13
2025-04-03P, purchase reported on Form 4120,770$1.4M2025-04-07
2025-04-04P, purchase reported on Form 4196,438$2.2M2025-04-07

Nuvation Bio Inc. (NUVB)

Director · 2 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-02-19P, purchase reported on Form 45,143,000$6.5M2023-09-21
2023-02-20P, purchase reported on Form 4117,100$159.3K2023-09-21
2023-02-21P, purchase reported on Form 453,000$72.1K2023-09-21

Aktis Oncology, Inc. (AKTS)

Director · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-01-12P, purchase reported on Form 42,077,779$37.4M2026-01-12
2026-01-12P, purchase reported on Form 4144,443$2.6M2026-01-12

PANA

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1454385) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms